Glucophage

Glucophage is a prescription medication whose active ingredient is metformin hydrochloride, a biguanide class oral antidiabetic drug. It is marketed in the European Union and is supplied in an oral dosage form, typically as tablets, though specific strengths may vary. Metformin works by decreasing hepatic glucose production and improving peripheral insulin sensitivity, helping to control blood sugar levels in patients with certain metabolic conditions including type 2 diabetes.

Glucophage is indicated for the management of several endocrine and metabolic disorders, primarily to improve glycemic control and address insulin resistance.

- Type 2 diabetes mellitus, used together with diet, exercise, and other antidiabetic agents. - Polycystic ovary syndrome (PCOS), to reduce insulin resistance and help regulate menstrual cycles. - Prediabetes, to lower fasting glucose and decrease the risk of progression to overt diabetes. - Gestational diabetes, as an alternative when insulin therapy is not feasible (off‑label).

Like all medications, Glucophage may cause side effects; they are generally categorized by frequency and severity.

Common: - Nausea, vomiting, or general stomach upset, especially when therapy is initiated. - Diarrhea, which may be watery and occur several times daily. - Abdominal discomfort, cramping, or bloating that often improves with continued use. - A metallic or bitter taste in the mouth that usually resolves over time.

Serious: - Lactic acidosis, a rare metabolic complication characterized by rapid breathing, muscle pain, and feeling cold; requires immediate medical attention. - Severe skin reactions, including Stevens‑Johnson syndrome or toxic epidermal necrolysis, presenting with rash, blistering, and fever. - Persistent vomiting or inability to retain fluids, leading to dehydration and electrolyte imbalance.

Before starting Glucophage, patients and clinicians should consider several precautionary measures to ensure safe and effective therapy.

- Assess kidney function; avoid use in severe renal impairment. - Monitor liver enzymes, as hepatic disease may increase risk of lactic acidosis. - Evaluate for heart failure or recent myocardial infarction, conditions that heighten lactic acidosis risk. - Use caution in older adults, who may have reduced renal clearance. - Review all concomitant medications for potential interactions, especially contrast agents used in imaging studies. - Advise patients to report unexplained muscle pain, weakness, or rapid breathing promptly.

Glucophage can interact with other medicines, affecting its efficacy or increasing the risk of adverse effects.

Avoid: - Iodinated contrast media used for radiographic procedures, which can impair renal function. - Cimetidine, a histamine H2‑receptor antagonist that may increase metformin plasma levels. - Certain antivirals such as didanosine, which can raise the risk of lactic acidosis.

Use with caution: - Diuretics, especially loop diuretics, which may affect hydration and renal function. - Beta‑blockers, as they can mask symptoms of hypoglycemia. - Alcohol, because excessive intake may increase the risk of lactic acidosis.